Predictors of mortality in rheumatoid arthritis-related interstitial lung disease

Respirology

Volumn 19, Issue 4, 2014, Pages 493-500

  Assayag, Deborah ^a   Lubin, Molly ^a   Lee, Joyce S ^a   King, Talmadge E ^a   Collard, Harold R ^a   Ryerson, Christopher J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

interstitial lung disease; mortality; prognosis; rheumatoid arthritis; systematic review

Indexed keywords

CARBON MONOXIDE; LACTATE DEHYDROGENASE;

AGE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ACTIVITY SCORE; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FORCED VITAL CAPACITY; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG BIOPSY; LUNG DIFFUSION CAPACITY; LUNG FIBROSIS; LUNG FUNCTION; MASCULINITY; MORTALITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SMOKING; SURVIVAL; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY; AGED; ARTHRITIS, RHEUMATOID; COMPLICATION; DISEASE MANAGEMENT; EPIDEMIOLOGY; FEMALE; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PATIENT ACUITY; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE;

AGED; ARTHRITIS, RHEUMATOID; CONFOUNDING FACTORS (EPIDEMIOLOGY); DISEASE MANAGEMENT; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; OBSERVATIONAL STUDY AS TOPIC; PATIENT ACUITY; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE;

EID: 84896316622     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12234     Document Type: Review

References (34)

1. Gabriel SE,. The epidemiology of rheumatoid arthritis. Rheum. Dis. Clin. North Am. 2001; 27: 269-281.
2. Bongartz T, Nannini C, Medina-Velasquez YF, Achenbach SJ, Crowson CS, Ryu JH, Vassallo R, Gabriel SE, Matteson EL,. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2010; 62: 1583-1591.
3. Picchianti Diamanti A, Germano V, Bizzi E, Lagana B, Migliore A,. Interstitial lung disease in rheumatoid arthritis in the era of biologics. Pulm. Med. 2011; 2011: 931342.
4. Olson AL, Swigris JJ, Sprunger DB, Fischer A, Fernandez-Perez ER, Solomon J, Murphy J, Cohen M, Raghu G, Brown KK,. Rheumatoid arthritis-interstitial lung disease-associated mortality. Am. J. Respir. Crit. Care Med. 2011; 183: 372-378.
5. Brown KK,. Rheumatoid lung disease. Proc. Am. Thorac. Soc. 2007; 4: 443-448.
6. Kim EJ, Collard HR, King JTE,. Rheumatoid arthritis-associated interstitial lung diseasethe relevance of histopathologic and radiographic pattern. CHEST J. 2009; 136: 1397-1405.
7. Lee HK, Kim DS, Yoo B, Seo JB, Rho JY, Colby TV, Kitaichi M,. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 2005; 127: 2019-2027.
8. Dixon WG, Hyrich KL, Watson KD, Lunt M, Bsrbr Control Centre C, Symmons DP, British Society for Rheumatology Biologics Register,. Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register. Ann. Rheum. Dis. 2010; 69: 1086-1091.
9. Kim EJ, Elicker BM, Maldonado F, Webb WR, Ryu JH, Van Uden JH, Lee JS, King TE, Collard HR,. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur. Respir. J. 2010; 35: 1322-1328.
10. Nakamura Y, Suda T, Kaida Y, Kono M, Hozumi H, Hashimoto D, Enomoto N, Fujisawa T, Inui N, Imokawa S, et al. Rheumatoid lung disease: prognostic analysis of 54 biopsy-proven cases. Respir. Med. 2012; 106: 1164-1169.
11. Nakamura Y, Suda T, Kono M, Kaida Y, Enomoto N, Hashimoto D, Fujiswa T, Inui N, Imokawa S, Hayakawa H, et al. Prognostic significance of histopahotlogic and radiographic pattern in interstitial lung disease associated with rheumatoid arthritis. Am. J. Respir. Crit. Care Med. 2011; 183: A3031.
12. Solomon JJ, Ryu J, Tazelaar H, Myers JL, Tuder R, Cool C, Swigris JJ, Brown KK,. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Proceedings of the American Thoracic Society 2011 International Conference; 13-18 May 2011, Denver, CO, USA.
13. Tsuchiya Y, Takayanagi N, Sugiura H, Miyahara Y, Tokunaga D, Kawabata Y, Sugita Y,. Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. Eur. Respir. J. 2011; 37: 1411-1417.
14. Wolfe F, Caplan L, Michaud K,. Rheumatoid arthritis treatment and the risk of severe interstitial lung disease. Scand. J. Rheumatol. 2007; 36: 172-178.
15. Lee H, Choe JY, Kim SK, Park SH, Kim JH, Hyun DS, Jung KJ, Bae J,. Important prognostic factor in rheumatoid arthritis patients with interstitial lung disease is not usual interstitial pneumonia pattern but interstitial lung disease extent on chest high-resolution computed tomography. Annu. Sci. Meet. Am. Coll. Rheumatol. Assoc. Rheumatol. Health Prof. 2012 Washington, DC U. S. 2012; 64: S528.
16. Solomon JJ, Russell GM, Ketzer JB, Olson AL, Fernandez-Perez ER, Huie TJ, Swigris JJ, Brown KK, Fischer A,. Rheumatoid arthritis-associated interstitial lung disease: clinical spectrum of a large cohort from a respiratory referral center. Annu. Sci. Meet. Am. Coll. Rheumatol. Assoc. Rheumatol. Health Prof. 2012 Washington, DC U. S. 2012; 64: S524-525.
17. Koduri G, Norton S, Young A, Cox N, Davies P, Devlin J, Dixey J, Gough A, Prouse P, Winfield J, et al. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology 2010; 49: 1483-1489.
18. Solomon JJ, Ryu JH, Tazelaar HD, Myers JL, Tuder R, Cool CD, Curran-Everett D, Fischer A, Swigris JJ, Brown KK,. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Respir. Med. 2013; 107: 1247-1252.
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31: 315-324.
20. Nakamura Y, Suda T, Kono M, Kaida Y, Enomoto N, Hashimoto D, Fujiswa T, Inui N, Imokawa S, Hayakawa H, et al. Prognostic significance of histopahotlogic and radiographic pattern in interstitial lung disease associated with rheumatoid arthritis. Proceedings of the American Thoracic Society 2011 International Conference; 13-18 May 2011, Denver, CO, USA.
21. Bouros D, Wells AU, Nicholson AG, Colby TV, Polychronopoulos V, Pantelidis P, Haslam PL, Vassilakis DA, Black CM, du Bois RM,. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am. J. Respir. Crit. Care Med. 2002; 165: 1581-1586.
22. Park JH, Kim DS, Park I-N, Jang SJ, Kitaichi M, Nicholson AG, Colby TV,. Prognosis of fibrotic interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2007; 175: 705-711.
23. Goh NSL, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, Corte TJ, Sander CR, Ratoff J, Devaraj A, et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am. J. Respir. Crit. Care Med. 2008; 177: 1248-1254.
24. Moore OA, Goh N, Corte T, Rouse H, Hennessy O, Thakkar V, Byron J, Sahhar J, Roddy J, Gabbay E, et al. Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Rheumatology 2013; 52: 155-160.
25. King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM,. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am. J. Respir. Crit. Care Med. 2001; 164: 1171-1181.
26. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier J-F, Flaherty KR, Lasky JA, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 2011; 183: 788-824.
27. Han MK, Murray S, Fell CD, Flaherty KR, Toews GB, Myers J, Colby TV, Travis WD, Kazerooni EA, Gross BH, et al. Sex differences in physiological progression of idiopathic pulmonary fibrosis. Eur. Respir. J. 2008; 31: 1183-1188.
28. Mogulkoc N, Brutsche MH, Bishop PW, Greaves SM, Horrocks AW, Egan JJ,. Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am. J. Respir. Crit. Care Med. 2001; 164: 103-108.
29. Shin KM, Lee KS, Chung MP, Han J, Bae YA, Kim TS, Chung MJ,. Prognostic determinants among clinical, thin-section CT, and histopathologic findings for fibrotic idiopathic interstitial pneumonias: tertiary hospital study1. Radiology 2008; 249: 328-337.
30. Edey AJ, Devaraj AA, Barker RP, Nicholson AG, Wells AU, Hansell DM,. Fibrotic idiopathic interstitial pneumonias: HRCT findings that predict mortality. Eur. Radiol. 2011; 21: 1586-1593.
31. Lee SH, Shim HS, Cho SH, Kim SY, Lee SK, Son JY, Jung JY, Kim EY, Lim JE, Lee KJ, et al. Prognostic factors for idiopathic pulmonary fibrosis: clinical, physiologic, pathologic, and molecular aspects. Sarcoidosis Vasc. Diffuse Lung Dis. 2011; 28: 102-112.
32. American Thoracic Society/European Respiratory Society International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2002; 165: 277-304.
33. Lynch DA, Godwin JD, Safrin S, Starko KM, Hormel P, Brown KK, Raghu G, King TE, Bradford WZ, Schwartz DA, et al.; Group ftIPFS. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am. J. Respir. Crit. Care Med. 2005; 172: 488-493.
34. Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, Lee JS, Poletti V, Buccioli M, Elicker BM, Jones KD, et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann. Intern. Med. 2012; 156: 684-691.